Viewing Study NCT00031733


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2025-12-26 @ 1:40 AM
Study NCT ID: NCT00031733
Status: COMPLETED
Last Update Posted: 2014-05-22
First Post: 2002-03-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
Sponsor: University of Southern California
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-02
Start Date Type: None
Primary Completion Date: 2004-12
Primary Completion Date Type: ACTUAL
Completion Date: 2007-11
Completion Date Type: ACTUAL
First Submit Date: 2002-03-08
First Submit QC Date: None
Study First Post Date: 2003-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-05-20
Last Update Post Date: 2014-05-22
Last Update Post Date Type: ESTIMATED